| The cGAS–STING pathway as a therapeutic target in inflammatory diseases A Decout, JD Katz, S Venkatraman, A Ablasser Nature Reviews Immunology 21 (9), 548-569, 2021 | 1051 | 2021 |
| Targeting STING with covalent small-molecule inhibitors SM Haag, MF Gulen, L Reymond, A Gibelin, L Abrami, A Decout, ... Nature 559 (7713), 269-273, 2018 | 754 | 2018 |
| Structural mechanism of cGAS inhibition by the nucleosome GR Pathare, A Decout, S Glück, S Cavadini, K Makasheva, R Hovius, ... Nature 587 (7835), 668-672, 2020 | 200 | 2020 |
| BAF restricts cGAS on nuclear DNA to prevent innate immune activation B Guey, M Wischnewski, A Decout, K Makasheva, M Kaynak, MS Sakar, ... Science 369 (6505), 823-828, 2020 | 156 | 2020 |
| Rational design of adjuvants targeting the C-type lectin Mincle A Decout, S Silva-Gomes, D Drocourt, S Barbe, I André, FJ Cueto, T Lioux, ... Proceedings of the National Academy of Sciences 114 (10), 2675-2680, 2017 | 114 | 2017 |
| Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2 A Decout, S Silva-Gomes, D Drocourt, E Blattes, M Rivière, J Prandi, ... Scientific reports 8 (1), 16840, 2018 | 47 | 2018 |
| Pathogen-associated molecular patterns (PAMPs) S Silva-Gomes, A Decout, J Nigou Encyclopedia of Inflammatory Diseases [Internet], 1-16, 2015 | 45 | 2015 |
| Virology: poxins soothe the STING A Decout, A Ablasser Current Biology 29 (9), R332-R334, 2019 | 1 | 2019 |
| Human cGAS has a slightly different taste for dsDNA A Decout, A Ablasser Immunity 49 (2), 206-208, 2018 | 1 | 2018 |
| Silent entry of mycobacteria into macrophages via Dectin-1? A Decout, G Tiraby, J Nigou FEBS JOURNAL 281, 168-168, 2014 | | 2014 |
| Group ID U12938 Affiliated authors Ablasser, Andrea NM Albrecher, J Ati, F Coquel, A Decout, GCG Fonteneau, S Glück, ... | | |
